The DrugAnalyst Global
THE definitive guide for investors in the Pharma sector.
Our 450 page workbook is published quarterly following earnings reports and sets out up-to-date market expectations for the coming quarter.
Provides an extensive top-down analysis of the global Pharma sector from macro trends to regional catalysts, therapeutic class developments to individual drugs, and of course a detailed review of each company looking at numbers to newsflow, pipeline development to valuation, the risks and catalysts.
We take on most up-to-date forecasts, look at the changes and trends, the deliverability, and the risks surrounding delivery.
DRUGANALYST Clients receive both physical Globals and access to the digital Global online.
Brutally honest, truly independent analysis.
You need to read this before investing in the Pharma sector.